Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Woerner

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Psychopharmacology Bulletin|January 1, 1988
The reliability of a shortened version of the SCL-90J M Alvir, N R Schooler, M T Borenstein, et al.
The American Journal of Psychiatry|June 1, 1993
Diabetes and development of tardive dyskinesiaM G Woerner, B L Saltz, J M Kane, et al.
Psychopharmacology Bulletin|January 1, 1989
Treatment outcome of first episode schizophreniaJ Lieberman, D Jody, S Geisler, et al.
Acta Psychiatrica Scandinavica|November 28, 2001
Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorderS Sevy, D G Robinson, S Holloway, et al.
Psychopharmacology Bulletin|January 1, 1989
Prospective study of tardive dyskinesia in the elderlyB L Saltz, J M Kane, M G Woerner, et al.
JAMA|November 6, 1991
Prospective study of tardive dyskinesia incidence in the elderlyB L Saltz, M G Woerner, J M Kane, et al.
Journal of Clinical Psychopharmacology|February 1, 1991
The prevalence of tardive dyskinesiaM G Woerner, J M Kane, J A Lieberman, et al.
Archives of General Psychiatry|March 17, 1999
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorderD Robinson, M G Woerner, J M Alvir, et al.
Archives of General Psychiatry|April 1, 1996
Incidence and correlates of tardive dyskinesia in first episode of schizophreniaM H Chakos, J M Alvir, M G Woerner, et al.
The American Journal of Psychiatry|April 14, 1999
Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorderD G Robinson, M G Woerner, J M Alvir, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Psychopharmacology Bulletin|January 1, 1988
The reliability of a shortened version of the SCL-90J M Alvir, N R Schooler, M T Borenstein, et al.
The American Journal of Psychiatry|June 1, 1993
Diabetes and development of tardive dyskinesiaM G Woerner, B L Saltz, J M Kane, et al.
Psychopharmacology Bulletin|January 1, 1989
Treatment outcome of first episode schizophreniaJ Lieberman, D Jody, S Geisler, et al.
Acta Psychiatrica Scandinavica|November 28, 2001
Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorderS Sevy, D G Robinson, S Holloway, et al.
Psychopharmacology Bulletin|January 1, 1989
Prospective study of tardive dyskinesia in the elderlyB L Saltz, J M Kane, M G Woerner, et al.
JAMA|November 6, 1991
Prospective study of tardive dyskinesia incidence in the elderlyB L Saltz, M G Woerner, J M Kane, et al.
Journal of Clinical Psychopharmacology|February 1, 1991
The prevalence of tardive dyskinesiaM G Woerner, J M Kane, J A Lieberman, et al.
Archives of General Psychiatry|March 17, 1999
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorderD Robinson, M G Woerner, J M Alvir, et al.
Archives of General Psychiatry|April 1, 1996
Incidence and correlates of tardive dyskinesia in first episode of schizophreniaM H Chakos, J M Alvir, M G Woerner, et al.
The American Journal of Psychiatry|April 14, 1999
Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorderD G Robinson, M G Woerner, J M Alvir, et al.
Pageof 4